Javascript must be enabled to continue!
Hypertensive disorders of pregnancy: heterogeneity in risk factors and maternal and neonatal outcomes across subtypes—a 6–year retrospective cohort study
View through CrossRef
Background
Hypertensive disorders of pregnancy (HDP) are major obstetric complications that seriously threaten maternal and neonatal health. Current research predominantly focuses on preeclampsia (PE). However, systematic comparisons across all four HDP subtypes—gestational hypertension (GH), preeclampsia (PE), chronic hypertension (CH), and superimposed preeclampsia (SPE) remain limited, hindering a deeper understanding of their heterogeneous risks and precise management.
Objective
This study aimed to systematically analyze the epidemiological trends, independent risk factors, and differential impacts on maternal and neonatal outcomes of HDP and its subtypes, based on large–sample clinical data.
Methods
This retrospective cohort study was conducted at a single tertiary care center in southern China, including 20,081 pregnant women who delivered at Guangxi Zhuang Autonomous Region People's Hospital between January 2019 and December 2024. Participants were classified into an HDP group (
n
= 1,334) and a non–HDP group (
n
= 18,747) based on discharge diagnoses. The HDP group was further subdivided into GH, PE, CH, and SPE. Baseline characteristics and pregnancy outcomes were collected. Multinomial logistic regression was used to identify factors associated with each HDP subtype vs. non-HDP. Multivariate logistic regression was used to assess associations between HDP subtypes and adverse outcomes, and adjusted models were constructed to assess independent risks. Given the small SPE sample (
n
= 24), CH and SPE were combined (CH-SPE) for multivariable analyses to ensure model stability. Sensitivity analyses separating CH and SPE were also performed to assess the robustness of findings.
Results
From 2019 to 2024, the overall incidence of HDP was 6.6%, with CH incidence increased by 78.2% (from 0.6% to 1.0%), and SPE incidence increased from 0.1% in 2019 to 0.7% in 2024. Multinomial analysis identified advanced maternal age (≥35 years), pre–pregnancy overweight/obesity, elevated fasting blood glucose (FBG), and gestational diabetes mellitus (GDM) as common risk factors for all HDP subtypes. Significant heterogeneity was observed among subtypes: PE demonstrated the strongest association with twin pregnancy (
OR
=4.071, 95%
CI
: 2.843––5.828), and elevated serum creatinine (Cr) was a specific risk factor for PE. CH–SPE was significantly associated with assisted reproductive technology (ART) (
OR
=2.032, 95%
CI
: 2.278––3.230), while higher education level was a unique protective factor (Postgraduate vs. Junior high school or below:
OR
=0.413, 95%
CI
: 0.259––0.660). All HDP subtypes significantly increased the risks of cesarean delivery with CH–SPE group (adjusted
OR
=3.399, 95%
CI
: 2.408––4.798) having the highest risk. Adverse neonatal outcomes (LBW and SGA) were predominantly concentrated in the PE and CH–SPE subtypes.
Conclusion
Significant heterogeneity exists in risk factors and maternal–neonatal outcomes across different HDP subtypes. This study highlights the rapidly increasing incidence and unique risk profiles of chronic hypertension–based subtypes, emphasizing the urgency for precise screening and management pre–pregnancy and during early gestation. The findings provide important evidence for subtype–stratified risk assessment and individualized clinical intervention in HDP.
Title: Hypertensive disorders of pregnancy: heterogeneity in risk factors and maternal and neonatal outcomes across subtypes—a 6–year retrospective cohort study
Description:
Background
Hypertensive disorders of pregnancy (HDP) are major obstetric complications that seriously threaten maternal and neonatal health.
Current research predominantly focuses on preeclampsia (PE).
However, systematic comparisons across all four HDP subtypes—gestational hypertension (GH), preeclampsia (PE), chronic hypertension (CH), and superimposed preeclampsia (SPE) remain limited, hindering a deeper understanding of their heterogeneous risks and precise management.
Objective
This study aimed to systematically analyze the epidemiological trends, independent risk factors, and differential impacts on maternal and neonatal outcomes of HDP and its subtypes, based on large–sample clinical data.
Methods
This retrospective cohort study was conducted at a single tertiary care center in southern China, including 20,081 pregnant women who delivered at Guangxi Zhuang Autonomous Region People's Hospital between January 2019 and December 2024.
Participants were classified into an HDP group (
n
= 1,334) and a non–HDP group (
n
= 18,747) based on discharge diagnoses.
The HDP group was further subdivided into GH, PE, CH, and SPE.
Baseline characteristics and pregnancy outcomes were collected.
Multinomial logistic regression was used to identify factors associated with each HDP subtype vs.
non-HDP.
Multivariate logistic regression was used to assess associations between HDP subtypes and adverse outcomes, and adjusted models were constructed to assess independent risks.
Given the small SPE sample (
n
= 24), CH and SPE were combined (CH-SPE) for multivariable analyses to ensure model stability.
Sensitivity analyses separating CH and SPE were also performed to assess the robustness of findings.
Results
From 2019 to 2024, the overall incidence of HDP was 6.
6%, with CH incidence increased by 78.
2% (from 0.
6% to 1.
0%), and SPE incidence increased from 0.
1% in 2019 to 0.
7% in 2024.
Multinomial analysis identified advanced maternal age (≥35 years), pre–pregnancy overweight/obesity, elevated fasting blood glucose (FBG), and gestational diabetes mellitus (GDM) as common risk factors for all HDP subtypes.
Significant heterogeneity was observed among subtypes: PE demonstrated the strongest association with twin pregnancy (
OR
=4.
071, 95%
CI
: 2.
843––5.
828), and elevated serum creatinine (Cr) was a specific risk factor for PE.
CH–SPE was significantly associated with assisted reproductive technology (ART) (
OR
=2.
032, 95%
CI
: 2.
278––3.
230), while higher education level was a unique protective factor (Postgraduate vs.
Junior high school or below:
OR
=0.
413, 95%
CI
: 0.
259––0.
660).
All HDP subtypes significantly increased the risks of cesarean delivery with CH–SPE group (adjusted
OR
=3.
399, 95%
CI
: 2.
408––4.
798) having the highest risk.
Adverse neonatal outcomes (LBW and SGA) were predominantly concentrated in the PE and CH–SPE subtypes.
Conclusion
Significant heterogeneity exists in risk factors and maternal–neonatal outcomes across different HDP subtypes.
This study highlights the rapidly increasing incidence and unique risk profiles of chronic hypertension–based subtypes, emphasizing the urgency for precise screening and management pre–pregnancy and during early gestation.
The findings provide important evidence for subtype–stratified risk assessment and individualized clinical intervention in HDP.
Related Results
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
Playing Pregnancy: The Ludification and Gamification of Expectant Motherhood in Smartphone Apps
IntroductionLike other forms of embodiment, pregnancy has increasingly become subject to representation and interpretation via digital technologies. Pregnancy and the unborn entity...
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
Nutrition in pregnancy
Nutrition in pregnancy
SUMMARY
INTRODUCTION
PHYSIOLOGICAL CHANGES DURING PREGNANCY
Changes in body composition and weight gain
Changes in blood composition
Metabolic changes and adaptive responses
K...
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Tracing Hematological Shifts in Pregnancy: How Anemia and Thrombocytopenia Evolve Across Trimesters
Abstract
Introduction
Given pregnancy's significant impact on hematological parameters, monitoring these changes across trimesters is crucial. This study aims to evaluate hematolog...
Is This A Fact? Hypertensive Disorder in 1st Pregnancy Recurs in 2nd Pregnancy
Is This A Fact? Hypertensive Disorder in 1st Pregnancy Recurs in 2nd Pregnancy
Background: Hypertensive disorder of pregnancy (HDP) entails a risk of recurrence in a subsequent pregnancy. Several risk factors have been associated with recurrence of hypertensi...
Cohort studies
Cohort studies
A cohort study is one in which the outcome (usually disease status) is ascertained for groups of individuals defined on the basis of their exposure. At the time exposure status is ...
Bell's palsy in pregnancy and puerperium
Bell's palsy in pregnancy and puerperium
<p dir="ltr">Pregnancy-associated Bell's palsy (Bell's palsy in pregnancy and puerperium, i.e., the first 6 weeks after childbirth) is thought to be more common than in the g...
Bell's palsy in pregnancy and puerperium
Bell's palsy in pregnancy and puerperium
<p dir="ltr">Pregnancy-associated Bell's palsy (Bell's palsy in pregnancy and puerperium, i.e., the first 6 weeks after childbirth) is thought to be more common than in the g...

